The Development of Rational Strategies for Selective Immunotherapy against Autoimmune Demyelinating Disease
- 1 January 1991
- book chapter
- Published by Elsevier in Advances in Immunology
- Vol. 49, 357-379
- https://doi.org/10.1016/s0065-2776(08)60779-8
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosisNature, 1990
- The T Lymphocyte in Experimental Allergic EncephalomyelitisAnnual Review of Immunology, 1990
- The V-region disease hypothesis: evidence from autoimmune encephalomyelitisImmunology Today, 1989
- The T-Cell Receptor Repertoire and Autoimmune DiseasesAnnual Review of Immunology, 1989
- T Cell Receptors in Murine Autoimmune DiseasesAnnual Review of Immunology, 1989
- Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapyCell, 1988
- A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple SclerosisNew England Journal of Medicine, 1987
- Correlation of T cell receptor V beta gene family with MHC restriction.The Journal of Experimental Medicine, 1987
- Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition.The Journal of Experimental Medicine, 1985
- Prevention of experimental allergic encephalitis with in vivo administration of anti I-A antibody☆Decreased accumulation of radiolabelled lymph node cells in the central nervous systemJournal of Neuroimmunology, 1983